Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
| Trades 289 | Longs Won 236/289 81% | Profit Factor 31.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $756,050.48 |
| Average Win $207,137.39 | Best Trade (Aug 05) $6.97M | Sharpe Ratio -13.89 |
| Average Loss -$29,190.87 | Worst Trade (Sep 01) -$304,909.83 | Z-Score 14.38 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 2w 4d | Expectancy $163,796.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,993 | 6,294 | 5,594 | 4,895 | 4,196 | 3,497 | 2,797 | 2,098 | 1,399 | 699 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 13,292 | $2.64M | $4.11M | - | $1.47M | 55.48% | -7.354% |
ALRS Alerus Financial Corporation | 50,279 | $1.13M | $1.67M | - | $547,035.35 | 48.59% | -0.864% |
AMZN Amazon.com Inc | 1,351 | $300,566.24 | $366,904.57 | - | $66,338.33 | 22.07% | +15.321% |
AOA iShares Core Aggressive Allocation ETF | 35,042 | $2.76M | $3.39M | - | $629,907.66 | 22.82% | +0.301% |
AOK iShares Core Conservative Allocation ETF | 15,197 | $551,533.32 | $621,861.24 | - | $70,327.92 | 12.75% | -0.049% |
AOM iShares Core 40/60 Moderate Allocation ETF | 12,335 | $533,785.9 | $605,401.82 | - | $71,615.92 | 13.42% | 0.0 |
AOR iShares Core 60/40 Balanced Allocation ETF | 86,813 | $4.67M | $5.95M | - | $1.28M | 27.4% | +0.058% |
BKAG BNY Mellon Core Bond ETF | 212,034 | $9.03M | $8.75M | - | -$272,636.5 | -3.02% | -0.242% |
BKIE BNY Mellon International Equity ETF | 213,216 | $6.38M | $7.23M | - | $845,997.1 | 13.26% | -0.703% |
BKLC BNY Mellon US Large Cap Core Equity ETF | 107,595 | $4.04M | $5.12M | - | $1.09M | 26.86% | +0.698% |
BRK-B Berkshire Hathaway Inc. | 2,360 | $889,167.16 | $1.21M | - | $318,067.24 | 35.77% | +0.365% |
BSV Vanguard Short-Term Bond ETF | 9,001 | $697,621.18 | $698,297.58 | - | $676.4 | 0.1% | -0.077% |
DKNG DraftKings Inc. | 10,974 | $368,073.48 | $257,669.52 | - | -$110,403.96 | -30% | -1.012% |
EEM iShares MSCI Emerging Markets ETF | 7,350 | $305,757.02 | $471,061.47 | - | $165,304.45 | 54.06% | +0.786% |
FNDA Schwab Fundamental U.S. Small Company ETF | 603,841 | $16.95M | $22.44M | - | $5.5M | 32.46% | -0.081% |
FNDE Schwab Fundamental Emerging Markets Large Company Index ETF | 178,420 | $5.04M | $7.37M | - | $2.32M | 46.06% | +0.658% |
FNDF Schwab Fundamental International Large Company Index ETF | 7,468 | $318,576.78 | $403,346.67 | - | $84,769.89 | 26.61% | -0.589% |
FNDX Schwab Fundamental U.S. Large Company Index ETF | 619,404 | $13.84M | $19.66M | - | $5.82M | 42.02% | +0.126% |
GE General Electric Company | 554 | $207,046 | $199,478.78 | - | -$7,567.22 | -3.65% | +1.417% |
GEV GE Vernova Inc. | 184 | $216,174 | $182,213.36 | - | -$33,960.64 | -15.71% | +0.846% |